FeesSafety
Pluang+

Proto Labs outperforms small-cap industrials 10x YTD, Q3 results due Oct 29 with expected revenue growth.

Company Fundamentals
21 Oct 2026
Seeking Alpha
View Source
Neutral
Proto Labs outperforms small-cap industrials 10x YTD, Q3 results due Oct 29 with expected revenue growth.

Proto Labs, a digital manufacturing company, has outperformed other small-cap industrial stocks by 10 times year-to-date. The company is set to report its Q3 results on October 29, expected to show a fourth consecutive quarter of revenue growth, though gross margins may soften. While customer numbers are stabilizing and revenue per customer is growing in double digits, the stock is currently expensive, trading at a 65% price-to-earnings premium with lower free cash flow and buyback yields compared to typical levels. Despite strong recent performance, the stock appears overextended within its sector.

Proto Labs and its recent performance provide context for this Industrials sector snapshot. For readers following Industrials, here is Pluang's market snapshot as of Oct 22, 2026 10:11 WIB: Of 135 priced US Industrials stocks, 88 rose and 45 fell today. Notable movers include ENVX at USD 2.49 with a 10.67% increase and 76% buy activity, SMX at USD 1.77 down 7.81% with 96% sell activity, and SPCX at USD 156.66 up 6.00% with nearly balanced buy/sell orders.

More News

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, a key infrastructure initiative aimed at strengthening the electricity network's security and resilience in the Balearic Islands. ...

Market News
Bullish
51 minutes ago
Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche reported a 7% sales increase at constant exchange rates in Q3 2026, with a 6% rise for the first nine months, fueled by high demand for key medicines like Xolair, Hemlibra, and Ocrevus. The Pharmaceuticals Division led growth, while Diagnostics...

Company Fundamentals
Bullish
51 minutes ago
Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen reported a 24.6% sales growth at constant exchange rates for the first nine months of 2026, driven by strong performance in Oncology, Rare Disease, and Neuroscience segments. The company upgraded its full-year sales growth guidance to around 23...

Company Fundamentals
Bullish
51 minutes ago
Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, aimed at enhancing the electricity network's security and resilience in the Balearic Islands. The project includes a six-month eng...

Market News
Bullish
51 minutes ago
Nexans reports 10.1% revenue growth in 9M 2026, confirms 2026 outlook with strong performance in electrification segments.

Nexans reports 10.1% revenue growth in 9M 2026, confirms 2026 outlook with strong performance in electrification segments.

Nexans posted a 10.1% increase in revenue to €4.95 billion for the first nine months of 2026, driven by strong organic growth in its electrification segments PWR-Grid and PWR-Connect. The company successfully integrated Republic Wire in the US and co...

Company Fundamentals
Bullish
51 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App